Ahmad Al Khleifat
De Crespigny Park
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Classical HLA class II associations with ALS in Kuwait reveal a DR7-DQ2.2 risk haplotype.
Journal: Frontiers in immunology
Published: March 01, 2026
Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.
Journal: Frontiers in neuroscience
Published: December 23, 2025
Plasma exosomal HERV-K transcripts are increased in amyotrophic lateral sclerosis.
Journal: BMC neuroscience
Published: November 07, 2025
CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.
Journal: Brain : a journal of neurology
Published: September 22, 2025
Biomarkers in ALS trials: from discovery to clinical utility.
Journal: Frontiers in neuroscience
Published: May 27, 2025
Entering the era of precision medicine to treat amyotrophic lateral sclerosis.
Journal: Molecular neurodegeneration
Published: March 26, 2025
Genetic and clinical landscape of Duchenne muscular dystrophy in Guatemala: insights from a national study.
Journal: Frontiers in genetics
Published: March 18, 2025
Sex-specific DNA methylation differences in Amyotrophic lateral sclerosis.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 12, 2024
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: October 25, 2024
Investigating the impact of socioeconomic status on amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 01, 2024
Last Updated: 09/26/2026